ABBOTT LABORATORIES A/S: Financial statements 2018
CVR: 31528615
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 128,992,247 and a net result of DKK -2,128,129 compared with DKK 5,706,415 the year before. That is a decrease of 12.5% compared with the year before. The profit margin was -1.6%. Equity in the 2018 report amounted to DKK 150,849,664. The solvency ratio was 80.6%. The company had 29 employees in the financial year.
- Revenue
- DKK 128,992,247
- Gross Profit
- DKK 22,501,930
- Profit/Loss
- DKK -2,128,129
- Equity
- DKK 150,849,664
- Total Assets
- DKK 187,175,052
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 129 mio. | 22.5 mio. | -2.1 mio. | 150.8 mio. | 29 |
| 2017 | 147.4 mio. | 34.4 mio. | 5.7 mio. | 58.9 mio. | 31 |
| 2016 | 134 mio. | 38.8 mio. | 3.3 mio. | 53.2 mio. | - |
| 2015 | 140.7 mio. | 43.9 mio. | 10.5 mio. | 49.8 mio. | - |
| 2014 | 149.8 mio. | 51.3 mio. | 15.1 mio. | 39.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ABBOTT LABORATORIES A/S has published its annual report for 2017. Revenue came to DKK 147,369,875, and the net result was DKK 5,706,415.
About ABBOTT LABORATORIES A/S
ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.